Celtaxsys, Inc.
Quick facts
Phase 2 pipeline
- CTX-4430 · Immunology
CTX-4430 is a small molecule inhibitor of the NADPH oxidase 2 (NOX2) enzyme.
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: